Menu Search
Equities

Align Technology Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AFW:DUS

Align Technology Inc

Actions
  • Price (EUR)162.65
  • Today's Change-2.90 / -1.75%
  • Shares traded7.00
  • 1 Year change-29.83%
  • Beta1.6359
Data delayed at least 15 minutes, as of Jul 18 2025 18:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

  • Revenue in USD (TTM)3.98bn
  • Net income in USD409.56m
  • Incorporated1997
  • Employees20.95k
  • Location
    Align Technology Inc410 North Scottsdale Road, Suite 1300TEMPE 85288United StatesUSA
  • Phone+1 (408) 470-1000
  • Fax+1 (408) 470-1010
  • Websitehttps://www.aligntech.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.